<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An enema that contained a complex of <z:chebi fb="6" ids="33301">bismuth</z:chebi> <z:chebi fb="2" ids="50744">citrate</z:chebi> and <z:chebi fb="0" ids="51134">polyacrylate</z:chebi> was compared with <z:chebi fb="0" ids="6775">5-aminosalicylic acid</z:chebi> (<z:chebi fb="0" ids="6775">5-ASA</z:chebi>) enemas for treatment of distal <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The multicentre trial involving 63 patients was randomised and double blind with enemas given over four weeks; clinical, sigmoidoscopic, and histological assessments were made </plain></SENT>
<SENT sid="2" pm="."><plain>Improvements were seen in both treatment groups </plain></SENT>
<SENT sid="3" pm="."><plain>Clinical remission was seen in 18 of 32 patients treated with <z:chebi fb="0" ids="6775">5-ASA</z:chebi> and 12 of 31 patients treated with <z:chebi fb="6" ids="33301">bismuth</z:chebi> <z:chebi fb="2" ids="50744">citrate</z:chebi>-carbomer (chi 2 1.94; p = 0.16) </plain></SENT>
<SENT sid="4" pm="."><plain>Sigmoidoscopic remission occurred in 20 of 32 patients in the <z:chebi fb="0" ids="6775">5-ASA</z:chebi> group and 15 of 31 patients given <z:chebi fb="6" ids="33301">bismuth</z:chebi> (chi 2 1.27; p = 0.26) </plain></SENT>
<SENT sid="5" pm="."><plain>Improvement of rectal biopsy histology by at least one grade was seen in 16 of 32 patients in the <z:chebi fb="0" ids="6775">5-ASA</z:chebi> group and 14 of 31 patients with <z:chebi fb="6" ids="33301">bismuth</z:chebi> (chi 2 0.15; p = 0.70) </plain></SENT>
<SENT sid="6" pm="."><plain>Analysis of covariance gave no significant difference between groups, although there was a trend favouring <z:chebi fb="0" ids="6775">5-ASA</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>There was no evidence of <z:chebi fb="6" ids="33301">bismuth</z:chebi> accumulation during the trial </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="6" ids="33301">Bismuth</z:chebi> enemas may offer a new therapeutic option in distal <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> </plain></SENT>
</text></document>